Insights from 2023 ESMO Annual Meeting
Lung
Insights from 2023 ESMO Annual Meeting
PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EGFR Exon 20 Insertion-Mutated Advanced NSCLC
FEATURING
Nicolas Girard
- 829 views
- November 17, 2023
- 7
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "TROPION-Lung01 Study - Dato-DXd vs. Docetaxel in Previously Treated Advanced/Metastatic NSCLC"
FEATURING
Aaron Lisberg
- 323 views
- November 17, 2023
- 3
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Recent Developments in the Treatment of Patients With EGFR ex 20 Ins NSCLC"
FEATURING
Paul Mitchell
- 306 views
- November 10, 2023
- 1
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "RAMOSE Trial - Osimertinib+/-Ramucirumab in TKI-Naïve EGFRm mNSCLC"
FEATURING
Xiuning Le
- 229 views
- November 8, 2023
- 2
Insights from 2023 ESMO Annual Meeting
Perioperative Immunotherapy Strategies in Resectable NSCLC After ESMO 2023
FEATURING
Giannis Mountzios
- 739 views
- October 30, 2023
- 14